Exploring New Spheres

Exploring New Spheres

Whether used for diagnostics or in prosthetic implants, Magle’s tailored microspheres hold great promise. A specific size facilitates cell growth and stimulates wound healing. Fluid absorption is essential for rapid hemostasis and sphere compressibility is vital for efficient embolization. Biodegradability enables use in ophthalmology and sustained local drug delivery.

Proven Technology

Proven Technology

Magle’s portfolio of registered products includes Arista® – marketed by Medafor Inc for surgical hemostasis; the product Spherex® – used in transarterial chemoembolization for the treatment of liver tumors; and Phadebas® – used in forensic labs worldwide for detection of biological traces. Phadebas also supports the diagnosis of pancreatitis.

Cutting Edge Competence

Cutting Edge Competence

Magle’s microspheres are made using natural polymers of plant origin and are designed and developed in accordance with ISO13485 quality standards. Final production takes place under GMP in facilities approved by the FDA. Magle’s highly skilled R&D team has ample experience in developing both medical devices and pharmaceuticals.

Biodegradable Microspheres in Healthcare

Magle strives to excel in the technical and medical development of polysaccharide products for healthcare. Our core knowledge is rooted in the design and development of in-vivo Degradable Starch Microspheres (DSM). Read more about Magle »